Infectious Diseases
Latest news
256 articles · 20 / page
Symptomatic Respiratory Disease and COVID-19 Testing Among Healthcare Workers: Insights from the Post-Pandemic Era in Ireland
A recent Irish study reveals that 6 in 10 healthcare workers with respiratory symptoms test for COVID-19, while vaccination coverage remains low, highlighting ongoing risks and the need for enhanced infection control and vaccination strateg
COVID reinfection may raise risk of persistent symptoms by 35%
Observational data from the RECOVER Initiative suggest that SARS-CoV-2 reinfection raises the risk of long COVID by 35% relative to single infections, with more recent vaccination potentially mitigating this risk.
Sex-Specific Impact of COVID-19 on Vascular Aging: Evidence from the CARTESIAN Study
COVID-19 accelerates vascular aging by approximately 5 years, disproportionately affecting women, with vaccination conferring protection primarily in females, highlighting sex-specific immunological responses and long-term vascular risks.
Razor Blade COVID-19 Variant Drives Up Cases in the U.S.
The Stratus variant, known as XFG, now dominates COVID-19 cases in the U.S., complicating recovery efforts amidst rising infections and changing vaccine guidance.
Diverging Pediatric Recommendations on COVID-19 Vaccination: The AAP Advocates Routine Immunization for Young Children Amid Federal Policy Shift
The American Academy of Pediatrics recommends COVID-19 vaccination for all young children aged 6-23 months, diverging from current CDC policies that advise shared decision-making for healthy children. This review analyzes epidemiologic data
Sulopenem versus Amoxicillin/Clavulanate for Uncomplicated Urinary Tract Infection: A Comprehensive Clinical Review
Sulopenem demonstrates noninferior efficacy to amoxicillin/clavulanate in treating uncomplicated UTI with a higher rate of mild adverse events, amidst rising antimicrobial resistance challenges.
Long-term Safety and Efficacy of Rabies Monoclonal Antibody and Vaccine for Post-Exposure Prophylaxis: Insights from a Phase 4 Trial in India
A phase 4 randomized trial demonstrates that combining rabies monoclonal antibody with vaccine in category 3 exposures is safe, immunogenic, and effective in preventing rabies up to one year post-exposure.
Nature: Influenza and SARS‑CoV‑2 can awaken dormant breast cancer cells and trigger lung metastasis
A Nature paper shows influenza and SARS‑CoV‑2 lung infections can reactivate dormant disseminated breast cancer cells (DCCs) via IL‑6 and CD4+ T‑cell–mediated mechanisms, with concordant human data linking SARS‑CoV‑2 infection to higher can
Balancing Copper Antimicrobials: A Double-Edged Tool in the Fight Against Antibiotic Resistance
Laboratory evolution shows copper exposure can select for antibiotic cross-resistance in Escherichia coli, but resistance may reverse quickly after copper withdrawal — supporting strategic, time-limited use and surveillance of copper-based
Antimicrobial Resistance and Healthcare Costs in Vietnam: Insights from a Six-Year Hospital Study
A major Vietnamese tertiary hospital study reveals substantial incremental costs and lengths of stay associated with antimicrobial-resistant ESKAPE pathogens, particularly during the COVID-19 pandemic.
Woman Develops Brain Infection After Eating Overnight Refrigerated Watermelon: Caused by Listeria Bacteria
A 38-year-old woman suffered a serious brain infection after consuming leftover refrigerated watermelon contaminated with Listeria. This article explains the risks of Listeria, symptoms, and prevention tips to ensure food safety.
Common Infectious Diseases in Summer and Their Prevention
An overview of common infectious diseases during summer, their symptoms, transmission, and preventive measures to protect public health.
M72/AS01E-4 Tuberculosis Vaccine: Promising Advances for HIV-Positive Populations in High-Burden Settings
A phase 2 trial in South Africa shows that the M72/AS01E-4 TB vaccine is safe and immunogenic for virally suppressed, ART-treated HIV-positive adolescents and adults, supporting its potential to address a key unmet clinical need.
Long COVID and the Workforce: Navigating a Complex Path Back to Employment
Long COVID is keeping millions of workers out of the workforce, with significant barriers to compensation and treatment. Standardized diagnostics, validated therapies, and regulatory reforms are urgently needed to support affected individua
Can Merely Seeing Infection Activate Real Immunity? The Neuroscience of Virtual Pathogens and Immunological Anticipation
A pioneering study demonstrates that visual cues of infection in virtual reality can trigger real immune activation, revealing a rapid neural-immune interface with potential implications for medicine, psychology, and vaccine development.
Optimizing Daptomycin Use in Japanese Pediatric Patients: The Critical Roles of Dose and Renal Function
A multicenter study in Japan found that adequate daptomycin dosing significantly improves clinical outcomes in pediatric patients, while adverse events can occur regardless of renal function.
Probiotics and Prebiotics: Unlocking the Secrets of Gut Health and Immunity
Explore how probiotics and prebiotics fortify gut health, boosting immune response and overall well-being.
Norfloxacin, Levofloxacin, Moxifloxacin: 3 Minutes to Understand the Differences, Misuse Harms Your Health!
“Take Norfloxacin for diarrhea, Levofloxacin for urinary tract infections, and Moxifloxacin for pneumonia” – this...
Real-World Safety and Effectiveness of MVA-BN Vaccination Against Mpox: Evidence from German, Systematic Review, and Immunogenicity Cohorts
MVA-BN vaccination is safe and effective against mpox in at-risk populations, but reduced protection is noted in people living with HIV. Dose strategies and patient immunological status may affect outcomes.
Individualised Versus Standard 10-Day Antibiotic Therapy in Pediatric Febrile UTI: Insights from the INDI-UTI Trial
A Danish multicentre trial found individualised, shorter antibiotic regimens for febrile pediatric UTIs reduce overall antibiotic exposure and adverse events, but with a modestly higher recurrence risk compared to standard 10-day treatment.
Browse by specialty
Open language-specific specialty feeds and department pages.